Abstract:Objective To study the influence of erythromycin on the pharmacokinetics of clonazepam (CZP) and the related mechanisms including the biochemistry (hepatic microsomal P450ase) and morphology (ultrastructure) Methods Forty eight P77 PMC rats, a kind of genetic aural epilepsy model, were included in the experiment To explore effects of erythromycin on the pharmacokinetics of clonazepam, 24 male P77 PMC rats, weighing 300 g, were randomly divided into two groups, the control group ( n =12) and study group ( n =12) In control group, CZP [2 0 mg/(kg·d)] was administrated once by intraperitoneal injection In study group, erythromycin [100 mg/(kg·d)] was administrated daily by intraperitoneal injection for 7 days, then CZP was injected at the same dosage on the 8th day The blood was drawn after 15, 30, 60, 90, 120, 180, 240, 360, 480 and 600 min of injection of CZP in the two groups The blood concentration of CZP was measured by HPLC (high pressure liquid chromatogram) The pharmacokinatics parameter was calculated with 3P87 software To study the mechanism, another 24 male P77PMC rats, weighing 300 g, were randomly divided into three groups, control group ( n =8), CZP group [ n =8, 2 0 mg/(kg·d) for 7 days] and erythromycin group [ n =8, 100 mg/(kg·d) for 7 days] The hepatic microsomal cytochrome protein was measured with lowry′s method The hepatic microsomal cytochrome P450ase was measured and calculated with Omura′s and Sato′s methods The hepatic ultrastructure was observed under the transmission electron microscope Eventually SPSS/PC software was used for the statistical analysis Results (1) The CZP blood concentration in the study group increased significantly at each time point ( P 0 01) (2) T1/2(2 20 h), AUC [296 59 ng/(ml·h)] and Cmax (253 25 ng/ml) of CZP in the study group significantly increased compared with those in the control group [1 18 h, 188 37 ng/(ml·h) and 128 84 ng/ml, respectively] (3) The content of the hepatic microsomal P450ase in erythromycin group [(0 24± 0 05) nmol/ mg(pro)] significantly decreased ( F =2 15, P 0 05) compared with that in CZP group [(0 34±0 07) nmol/mg(pro)] and control group [(0 37±0 04) nmol/mg(pro)] (4) The numbers of smooth endoplasmic reticulum in hepatic cells decreased and the structure was destroyed by using erythromycin. Conclusion Erythromycin showed a significant inhibition on the metabolism of CZP The related mechanism might be the destroy of smooth endoplasmic reticulum in hepatic cells and the decrease of hepatic microsomal P450ase because of the administration of erythromycin It is suggested that the dosage of CZP should be adjusted according to the blood concentration when CZP is administered with the combination of erythromycin

Influence and Mechanism of Erythromycin on the Pharmacokinetics of Clonazepam